Furthermore, the serum CHI3L1 levels were significantly higher in patients with large-artery atherosclerosis (LLA) stroke than in healthy controls, suggesting that CHI3L1 is an independent prognostic biomarker for the prediction of the clinical outcomes of LLA stroke146. Here, CHI3L1 is linked to stroke disorder.